{"id":9780,"date":"2026-09-22T14:39:28","date_gmt":"2026-09-22T12:39:28","guid":{"rendered":"https:\/\/antaresvisiongroup.com\/lifescience\/?page_id=9780"},"modified":"2026-09-22T14:39:30","modified_gmt":"2026-09-22T12:39:30","slug":"serializacao-e-agregacao-de-produtos-farmaceuticos","status":"publish","type":"page","link":"https:\/\/antaresvisiongroup.com\/lifescience\/pt\/serializacao-e-agregacao-de-produtos-farmaceuticos\/","title":{"rendered":"Serializa\u00e7\u00e3o e agrega\u00e7\u00e3o de produtos farmac\u00eauticos"},"content":{"rendered":"\n<div class=\"kbreadcrumb\" id=\"k_year\">\n    <div class=\"pure-container\">\n        <div class=\"pure-g\">\n            <div class=\"pure-u-1-1\">\n                <div class=\"breadcrumbs\"><a href=\"https:\/\/antaresvisiongroup.com\/lifescience\">Home<\/a> | <\/div>            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div class=\"k-block-css\" hidden data-css=\"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\"><\/div>\n\n    <div class=\"pure-containerFluid pureCol \">\n    <div class=\"pure-container\">         <div class=\"pure-row\">\n            <div class=\"pure-g\">\n                <div class=\"pure-u-1-1 pure-u-md-16-24 offset-md-1-6\">\n\n\n\n\n<div class=\"k-block-css\" hidden data-css=\"CgogICAgLmZvcm1Db250YWN0cyBpbnB1dFt0eXBlPSJzdWJtaXQiXXsgYmFja2dyb3VuZC1jb2xvcjogcmdiKCwsKTsgYm9yZGVyOiAwOwogICAgY29sb3I6ICNmZmZmZmY7IHRleHQtdHJhbnNmb3JtOiB1cHBlcmNhc2U7IHBhZGRpbmc6IDIwcHg7IGZvbnQtc2l6ZTogMTZweDsgZm9udC1mYW1pbHk6ICdSb2JvdG8nLCBzYW5zLXNlcmlmOwogICAgbWluLXdpZHRoOiAyNTBweDsgZm9udC13ZWlnaHQ6IDYwMDsgY3Vyc29yOiBwb2ludGVyOyBtYXJnaW4tdG9wOiAzMHB4O30KICAgIC5wdXJlQ29sIGF7Y29sb3I6IHJnYigsLCk7fQoKICAgIC8qIG1vYmlsZSAqLwogICAgQG1lZGlhIHNjcmVlbiBhbmQgKG1heC13aWR0aDogNzY3cHgpIHsKCiAgICB9CgogICAgLyogaXBhZCAqLwogICAgQG1lZGlhIHNjcmVlbiBhbmQgKG1pbi13aWR0aDogNzY4cHgpIGFuZCAgKG1heC13aWR0aDogOTkycHgpewoKICAgIH0KCiAgICAvKiBpcGFkIHBybyAqLwogICAgQG1lZGlhIHNjcmVlbiBhbmQgKG1pbi13aWR0aDogOTkycHgpIGFuZCAgKG1heC13aWR0aDogMTIwMHB4KXsKCiAgICB9Cgo=\"><\/div>\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"pure-container kbutton \"\n style=\"\">\n            <a class=\"gtm__conditionButton kbutton__button\" href=\"https:\/\/antaresvisiongroup.com\/lifescience\/track-and-trace\/\" target=\"\"\n                    >\n            <div class=\"kbutton__buttonTitle\">DISCOVER OUR SOLUTIONS<\/div>\n            <svg id=\"Livello_button\" data-name=\"Livello 2\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"14\" height=\"14\" viewBox=\"0 0 14 14\">\n                <defs>\n                    <div class=\"k-block-css\" hidden data-css=\"CiAgICAgICAgICAgICAgICAgICAgICAgIC5rYnV0dG9uIC5jbHMtMXtmaWxsOm5vbmU7fQogICAgICAgICAgICAgICAgICAgICAgICAua2J1dHRvbiAuY2xzLTJ7Y2xpcC1wYXRoOnVybCgjY2xpcC1wYXRoLTEpIWltcG9ydGFudDt9CiAgICAgICAgICAgICAgICAgICAgICAgIC5rYnV0dG9uIC5jbHMtM3tjbGlwLXBhdGg6dXJsKCNjbGlwLXBhdGgtMi0xKSFpbXBvcnRhbnQ7fQogICAgICAgICAgICAgICAgICAgICAgICAua2J1dHRvbiAuY2xzLTR7Y2xpcC1wYXRoOnVybCgjY2xpcC1wYXRoLTMtMSkhaW1wb3J0YW50O30KICAgICAgICAgICAgICAgICAgICAgICAgLmtidXR0b24gLmNscy01e2ZpbGw6IHJnYigsLCkhaW1wb3J0YW50O30KICAgICAgICAgICAgICAgICAgICA=\"><\/div>\n                    <clipPath id=\"clip-path-1\">\n                        <polygon class=\"cls-1\" points=\"2.099 12.999 1 11.9 10.344 2.557 1.824 2.557 1.824 1 13 1 13 12.176 11.443 12.176 11.443 3.656 2.099 12.999\"><\/polygon>\n                    <\/clipPath>\n                    <clipPath id=\"clip-path-2-1\">\n                        <rect class=\"cls-1\" x=\"-1141\" y=\"-1543\" width=\"1680\" height=\"4770.9999\"><\/rect>\n                    <\/clipPath>\n                    <clipPath id=\"clip-path-3-1\">\n                        <rect class=\"cls-1\" x=\"1\" y=\"1\" width=\"12\" height=\"12\"><\/rect>\n                    <\/clipPath>\n                <\/defs>\n                <title>k-arrow-blu<\/title>\n                <g class=\"cls-2\"><g class=\"cls-3\"><g class=\"cls-4\"><g class=\"cls-4\"><rect class=\"cls-5\" width=\"14\" height=\"14\"><\/rect>\n                                <rect class=\"cls-5\" width=\"14\" height=\"14\"><\/rect>\n                            <\/g><\/g><\/g><\/g>\n            <\/svg>\n        <\/a>\n    <\/div>\n\n<div class=\"k-block-css\" hidden data-css=\"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\"><\/div>\n\n<div class=\"k-block-js\" hidden data-js=\"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\"><\/div>\n\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n<\/div>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<h1 class=\"wp-block-heading has-text-color has-link-color wp-elements-1\" style=\"color:#003865\"><strong><strong>Serializa\u00e7\u00e3o e agrega\u00e7\u00e3o de produtos farmac\u00eauticos<\/strong><\/strong><\/h1>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n<p class=\"wp-block-paragraph\">Desde a identifica\u00e7\u00e3o \u00fanica ao n\u00edvel do artigo at\u00e9 \u00e0 rastreabilidade completa da cadeia de abastecimento: um guia completo sobre a serializa\u00e7\u00e3o farmac\u00eautica, a agrega\u00e7\u00e3o, o software de serializa\u00e7\u00e3o e a conformidade com a DSCSA e a FMD da UE.<\/p>\n\n\n<p class=\"wp-block-paragraph\">A serializa\u00e7\u00e3o farmac\u00eautica consiste na atribui\u00e7\u00e3o de um identificador \u00fanico a cada embalagem individual de um medicamento, que \u00e9 normalmente codificado num c\u00f3digo de barras DataMatrix da GS1. A agrega\u00e7\u00e3o farmac\u00eautica regista as rela\u00e7\u00f5es hier\u00e1rquicas entre artigos, caixas e paletes serializados, o que permite a rastreabilidade da cadeia de abastecimento sem necessidade de digitalizar cada unidade em cada transfer\u00eancia. Em conjunto, a serializa\u00e7\u00e3o e a agrega\u00e7\u00e3o farmac\u00eauticas constituem a base de dados para a verifica\u00e7\u00e3o de produtos, o cumprimento da regulamenta\u00e7\u00e3o espec\u00edfica de cada mercado e a rastreabilidade farmac\u00eautica de in\u00edcio a fim.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n<h2 class=\"wp-block-heading\">Serializa\u00e7\u00e3o e agrega\u00e7\u00e3o de produtos farmac\u00eauticos: o que significa cada termo<\/h2>\n\n\n<p class=\"wp-block-paragraph\">A serializa\u00e7\u00e3o farmac\u00eautica e a agrega\u00e7\u00e3o farmac\u00eautica s\u00e3o dois processos distintos, mas interdependentes. A serializa\u00e7\u00e3o estabelece a identidade ao n\u00edvel do artigo. A agrega\u00e7\u00e3o estabelece as rela\u00e7\u00f5es entre os diferentes n\u00edveis de embalagem. Em conjunto, permitem a serializa\u00e7\u00e3o e a rastreabilidade dos produtos farmac\u00eauticos ao longo de toda a cadeia de abastecimento, embora o \u00e2mbito regulamentar exato varie consoante o mercado. A serializa\u00e7\u00e3o \u00e9 um requisito fundamental ao abrigo da DSCSA e da FMD da UE, enquanto a agrega\u00e7\u00e3o e a troca de eventos com base no EPCIS s\u00e3o obrigat\u00f3rias ou fortemente recomendadas em v\u00e1rios mercados e cen\u00e1rios da cadeia de abastecimento, especialmente nas opera\u00e7\u00f5es de venda por grosso e distribui\u00e7\u00e3o.<\/p>\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Serializa\u00e7\u00e3o farmac\u00eautica<\/strong> <br><br>Atribui um n\u00famero de s\u00e9rie \u00fanico a cada unidade individual. Codificado num c\u00f3digo de barras 2D GS1 DataMatrix na embalagem. Cont\u00e9m: GTIN + n\u00famero de s\u00e9rie + n\u00famero de lote + data de validade. \u00c9 aplicada ao n\u00edvel do artigo na linha de embalagem ou de encaixotamento. \u00c9 verificada por meio de um sistema de vis\u00e3o artificial \u00e0 velocidade da linha. \u00c9 registada ou comunicada ao reposit\u00f3rio ou sistema correspondente, sempre que necess\u00e1rio.<\/td><td><strong>Agrega\u00e7\u00e3o farmac\u00eautica<\/strong> <br><br>Regista as rela\u00e7\u00f5es hier\u00e1rquicas entre os diferentes n\u00edveis de embalagem. Estabelece uma liga\u00e7\u00e3o hier\u00e1rquica entre os artigos serializados \u2192 caixas \u2192 paletes. Permite a verifica\u00e7\u00e3o de caixas ou paletes atrav\u00e9s da leitura de um \u00fanico c\u00f3digo de barras. \u00c9 realizada no final da linha de produ\u00e7\u00e3o ou em esta\u00e7\u00f5es de agrega\u00e7\u00e3o espec\u00edficas. \u00c9 registada como eventos de agrega\u00e7\u00e3o numa camada de eventos compat\u00edvel com o EPCIS. \u00c9 obrigat\u00f3ria ou esperada do ponto de vista operacional em v\u00e1rios mercados e modelos de distribui\u00e7\u00e3o.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n<p class=\"wp-block-paragraph\">Serializa\u00e7\u00e3o e agrega\u00e7\u00e3o em conjunto: a serializa\u00e7\u00e3o e a agrega\u00e7\u00e3o s\u00e3o complementares; a serializa\u00e7\u00e3o atribui a cada unidade uma identidade \u00fanica a n\u00edvel global; a agrega\u00e7\u00e3o estabelece a hierarquia de embalagem que torna vi\u00e1vel a verifica\u00e7\u00e3o da cadeia de abastecimento em grande escala. Sem a agrega\u00e7\u00e3o, poderia ser necess\u00e1rio digitalizar individualmente cada unidade de uma caixa nos pontos de transfer\u00eancia. Com a agrega\u00e7\u00e3o, a digitaliza\u00e7\u00e3o de uma \u00fanica caixa ou palete pode proporcionar visibilidade de todas as caixas e artigos associados, desde que os parceiros comerciais e a legisla\u00e7\u00e3o apoiem essa hierarquia.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n<h2 class=\"wp-block-heading\">Tr\u00eas n\u00edveis de agrega\u00e7\u00e3o de dados farmac\u00eauticos<\/h2>\n\n\n<p class=\"wp-block-paragraph\">A agrega\u00e7\u00e3o de dados farmac\u00eauticos \u00e9 realizada em tr\u00eas n\u00edveis de embalagem. A estrutura hier\u00e1rquica dos dados \u2014 gerida por um software de serializa\u00e7\u00e3o e partilhada atrav\u00e9s de um sistema de gest\u00e3o de eventos compat\u00edvel com o EPCIS \u2014 permite uma verifica\u00e7\u00e3o eficaz da cadeia de abastecimento ao n\u00edvel do artigo, da caixa ou do palete, sem necessidade de desembalar.<\/p>\n\n\n<h3 class=\"wp-block-heading\"><strong>N\u00edvel 1 \u2014 Artigo (SGTIN)<\/strong><\/h3>\n\n\n<p class=\"wp-block-paragraph\">O n\u00edvel b\u00e1sico da serializa\u00e7\u00e3o de produtos farmac\u00eauticos. Cada artigo possui um identificador \u00fanico, frequentemente baseado num SGTIN e codificado num c\u00f3digo de barras GS1 DataMatrix. Nos pontos de dispensa ou verifica\u00e7\u00e3o, o n\u00famero de s\u00e9rie do artigo pode ser cruzado com o sistema de mercado relevante ou com o processo de interc\u00e2mbio de dados do parceiro comercial antes de o produto ser entregue ou transferido.<\/p>\n\n\n<h3 class=\"wp-block-heading\"><strong>N\u00edvel 2 \u2014 Embalagem (SGTIN \/ SSCC)<\/strong><\/h3>\n\n\n<p class=\"wp-block-paragraph\">O n\u00edvel de agrega\u00e7\u00e3o interm\u00e9dio. Os artigos serializados que se encontram dentro da caixa est\u00e3o associados ao identificador da mesma. A agrega\u00e7\u00e3o ao n\u00edvel da caixa permite que os grossistas, armaz\u00e9ns e outros parceiros comerciais verifiquem a movimenta\u00e7\u00e3o dos produtos, digitalizando a caixa do remetente em vez de cada unidade individual, o que constitui um dos principais benef\u00edcios operacionais da serializa\u00e7\u00e3o e da agrega\u00e7\u00e3o.<\/p>\n\n\n<h3 class=\"wp-block-heading\"><strong>N\u00edvel 3 \u2014 Palete (SSCC)<\/strong><\/h3>\n\n\n<p class=\"wp-block-paragraph\">O n\u00edvel de agrega\u00e7\u00e3o mais externo. Identificado atrav\u00e9s de um SSCC, o palete est\u00e1 associado \u00e0s caixas que cont\u00e9m. Ao digitalizar a etiqueta do palete num centro de distribui\u00e7\u00e3o, \u00e9 poss\u00edvel obter visibilidade das caixas e dos artigos associados, consoante a hierarquia de agrega\u00e7\u00e3o e o modelo de troca de dados utilizado. Esta \u00e9 a vantagem operacional que torna as solu\u00e7\u00f5es de agrega\u00e7\u00e3o de dados farmac\u00eauticos essenciais para a efici\u00eancia das opera\u00e7\u00f5es de com\u00e9rcio grossista e distribui\u00e7\u00e3o.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n<h2 class=\"wp-block-heading\">Software de serializa\u00e7\u00e3o: arquitetura e funcionalidades<\/h2>\n\n\n<p class=\"wp-block-paragraph\"><strong>O software de serializa\u00e7\u00e3o<\/strong> para fabricantes farmac\u00eauticos gere todo o ciclo de vida dos identificadores \u00fanicos das unidades de medicamento: desde a gera\u00e7\u00e3o e atribui\u00e7\u00e3o de n\u00fameros de s\u00e9rie at\u00e9 \u00e0 impress\u00e3o e verifica\u00e7\u00e3o ao n\u00edvel da linha de produ\u00e7\u00e3o, o registo de eventos <strong>de agrega\u00e7\u00e3o farmac\u00eautica<\/strong>, a implementa\u00e7\u00e3o regulamentar e a apresenta\u00e7\u00e3o de relat\u00f3rios sobre eventos na cadeia de abastecimento.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Uma solu\u00e7\u00e3o completa de serializa\u00e7\u00e3o farmac\u00eautica \u00e9 normalmente estruturada em v\u00e1rios n\u00edveis interligados: software e hardware ao n\u00edvel da linha de produ\u00e7\u00e3o (frequentemente designados por L1\/L2, que gerem os dispositivos de impress\u00e3o, verifica\u00e7\u00e3o por c\u00e2mara, rejei\u00e7\u00e3o e agrega\u00e7\u00e3o), software de serializa\u00e7\u00e3o ao n\u00edvel da f\u00e1brica ou centro (L3, que agrega os dados de todas as linhas, gere os lotes e a coloca\u00e7\u00e3o em servi\u00e7o) e software de conectividade empresarial ou regulamentar (L4\/L5, que gere os conjuntos globais de n\u00fameros de s\u00e9rie, a integra\u00e7\u00e3o com ERP\/MES, a troca de eventos EPCIS e a elabora\u00e7\u00e3o de relat\u00f3rios de conformidade regulamentar em v\u00e1rios mercados).<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>Gest\u00e3o de n\u00fameros de s\u00e9rie: Gera e <\/strong>gere s\u00e9ries de n\u00fameros de s\u00e9rie GS1 SGTIN. Evita duplicados, gere os n\u00fameros retirados e distribui as s\u00e9ries pelas unidades de produ\u00e7\u00e3o em todo o mundo.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>Impress\u00e3o e verifica\u00e7\u00e3o: Liga-se a <\/strong>impressoras de linha e <strong>a <\/strong>sistemas de c\u00e2maras para imprimir, ler e verificar c\u00f3digos DataMatrix 2D \u00e0 velocidade de produ\u00e7\u00e3o. Gere as reimpress\u00f5es e as rejei\u00e7\u00f5es sem interromper a linha de produ\u00e7\u00e3o.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>M\u00f3dulo de agrupamento: Regista eventos <\/strong>de rela\u00e7\u00e3o pai-filho entre artigos e caixas, e entre caixas e paletes. \u00c9 compat\u00edvel tanto com postos de trabalho de agrupamento manual como com c\u00e9lulas de agrupamento rob\u00f3ticas totalmente automatizadas.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Conectividade normativa: Conectividade com o EMVS\/NMVS para os fluxos de trabalho de interc\u00e2mbio e verifica\u00e7\u00e3o da UE no \u00e2mbito do FMD e do DSCSA nos EUA, bem como com outros reposit\u00f3rios espec\u00edficos de cada mercado ou sistemas nacionais, quando aplic\u00e1vel.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Integra\u00e7\u00e3o ERP\/MES: Sincroniza os dados mestre, os registos de lotes e as ordens de fabrico com o SAP, o Oracle e outros sistemas empresariais. As op\u00e7\u00f5es de integra\u00e7\u00e3o pr\u00e9-configuradas ou validadas podem reduzir o risco de implementa\u00e7\u00e3o.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>Relat\u00f3rios de conformidade: pain\u00e9is <\/strong>de controlo <strong>em tempo real sobre <\/strong>o estado da serializa\u00e7\u00e3o, a gest\u00e3o de exce\u00e7\u00f5es e os indicadores-chave de desempenho (KPI) regulamentares. Registo de auditoria completo para a reconstitui\u00e7\u00e3o de lotes.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n<h2 class=\"wp-block-heading\">Solu\u00e7\u00f5es de serializa\u00e7\u00e3o: desde uma \u00fanica linha de produ\u00e7\u00e3o at\u00e9 uma empresa global<\/h2>\n\n\n<p class=\"wp-block-paragraph\"><strong>As solu\u00e7\u00f5es de serializa\u00e7\u00e3o<\/strong> para fabricantes farmac\u00eauticos s\u00e3o concebidas para diferentes escalas. <strong>A solu\u00e7\u00e3o de serializa\u00e7\u00e3o farmac\u00eautica<\/strong> mais adequada depende do n\u00famero de produtos, dos mercados de destino, dos formatos de embalagem e do grau de integra\u00e7\u00e3o com o sistema ERP que for necess\u00e1rio.<\/p>\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>\u00c2mbito de aplica\u00e7\u00e3o<\/strong><\/td><td><strong>Descri\u00e7\u00e3o<\/strong><\/td><td><strong>Caso de utiliza\u00e7\u00e3o t\u00edpico<\/strong><\/td><\/tr><\/thead><tbody><tr><td>N\u00edvel de linha \/ L1-L2<\/td><td>Software e hardware de serializa\u00e7\u00e3o numa \u00fanica linha de embalagem. Gere os dispositivos de impress\u00e3o e verifica\u00e7\u00e3o, a inspe\u00e7\u00e3o por c\u00e2mara, a rejei\u00e7\u00e3o e a agrega\u00e7\u00e3o b\u00e1sica.<\/td><td>CMO, CDMO, fabricantes de um \u00fanico produto, projetos de serializa\u00e7\u00e3o pela primeira vez<\/td><\/tr><tr><td>Piso da f\u00e1brica \/ L3<\/td><td>Software de serializa\u00e7\u00e3o centralizado que gere v\u00e1rias linhas de embalagem numa mesma f\u00e1brica. \u00c9 respons\u00e1vel pelos registos de lotes, pela coloca\u00e7\u00e3o em funcionamento, pela agrega\u00e7\u00e3o, pelas altera\u00e7\u00f5es, pela gest\u00e3o das linhas e pela elabora\u00e7\u00e3o de relat\u00f3rios ao n\u00edvel da f\u00e1brica.<\/td><td>Empresas de produ\u00e7\u00e3o de m\u00e9dia dimens\u00e3o com v\u00e1rias linhas de embalagem<\/td><\/tr><tr><td>Empresa \/ L4-L5<\/td><td>Plataforma multiss\u00edtio com gest\u00e3o centralizada de n\u00fameros de s\u00e9rie, integra\u00e7\u00e3o com ERP\/MES, conformidade regulamentar e interc\u00e2mbio de dados EPCIS com parceiros comerciais. Gere a serializa\u00e7\u00e3o e a rastreabilidade de produtos farmac\u00eauticos em diversos mercados.<\/td><td>Fabricantes multinacionais e titulares de autoriza\u00e7\u00f5es de introdu\u00e7\u00e3o no mercado (MAH) que cumprem a DSCSA, a regulamenta\u00e7\u00e3o da UE relativa \u00e0 febre aftosa (FMD) e outros requisitos espec\u00edficos de cada mercado<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n<p class=\"wp-block-paragraph\">Escolha de uma solu\u00e7\u00e3o de serializa\u00e7\u00e3o farmac\u00eautica: O risco mais comum na implementa\u00e7\u00e3o \u00e9 subestimar o \u00e2mbito da integra\u00e7\u00e3o com o ERP e os dados mestre. Uma solu\u00e7\u00e3o de serializa\u00e7\u00e3o farmac\u00eautica que n\u00e3o esteja estreitamente integrada com o sistema de gest\u00e3o de lotes pode exigir a introdu\u00e7\u00e3o manual de dados durante a implementa\u00e7\u00e3o, o que gera tanto um risco de incumprimento regulamentar como um estrangulamento operacional. Procure experi\u00eancia comprovada em integra\u00e7\u00e3o com ERP\/MES como parte da avalia\u00e7\u00e3o da solu\u00e7\u00e3o.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n<h2 class=\"wp-block-heading\">Equipamentos de serializa\u00e7\u00e3o farmac\u00eautica: o que a linha de produ\u00e7\u00e3o precisa<\/h2>\n\n\n<p class=\"wp-block-paragraph\">Os equipamentos de serializa\u00e7\u00e3o farmac\u00eautica s\u00e3o os dispositivos f\u00edsicos instalados na linha de embalagem para imprimir, verificar e gerir n\u00fameros de s\u00e9rie \u00fanicos nas embalagens de medicamentos \u00e0 velocidade de produ\u00e7\u00e3o. A escolha dos equipamentos de serializa\u00e7\u00e3o farmac\u00eautica depende do formato da embalagem, da velocidade da linha, do suporte do c\u00f3digo, do design da m\u00e1quina do fabricante original (OEM) e do grau de automatiza\u00e7\u00e3o necess\u00e1rio para a agrega\u00e7\u00e3o. Estes sistemas podem ser integrados em novas linhas de embalagem atrav\u00e9s da colabora\u00e7\u00e3o com o fabricante original (OEM) ou instalados no \u00e2mbito de projetos de moderniza\u00e7\u00e3o ou renova\u00e7\u00e3o em linhas j\u00e1 existentes.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Sistemas de codifica\u00e7\u00e3o: jato de tinta de alta resolu\u00e7\u00e3o, laser ou TTO para c\u00f3digos DataMatrix e texto leg\u00edvel a olho nu em caixas de cart\u00e3o, etiquetas e folhas. A qualidade do c\u00f3digo deve ser medida e controlada de acordo com os requisitos de classifica\u00e7\u00e3o aplic\u00e1veis da GS1 e da ISO\/IEC.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>C\u00e2maras de verifica\u00e7\u00e3o visual: sistemas <\/strong>de c\u00e2maras <strong>integrados que <\/strong>l\u00eaem e classificam todos os c\u00f3digos DataMatrix \u00e0 velocidade da linha de produ\u00e7\u00e3o. Ativam a rejei\u00e7\u00e3o autom\u00e1tica de c\u00f3digos ileg\u00edveis ou danificados.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Mecanismos de rejei\u00e7\u00e3o: jatos de ar, bra\u00e7os impulsores ou sistemas desviadores que retiram as embalagens n\u00e3o conformes sem interromper a produ\u00e7\u00e3o. A efic\u00e1cia da rejei\u00e7\u00e3o deve ser validada no \u00e2mbito da qualifica\u00e7\u00e3o da linha.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>Postos de trabalho de agrupamento: Esta\u00e7\u00f5es <\/strong>de digitaliza\u00e7\u00e3o <strong>manuais ou <\/strong>semiautom\u00e1ticas nas quais os operadores digitalizam os artigos para os colocar em caixas e, por sua vez, as caixas em paletes. S\u00e3o utilizadas quando o volume \u00e9 insuficiente para as c\u00e9lulas de agrupamento automatizadas.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>C\u00e9lulas de agrupamento automatizadas: sistemas <\/strong> <strong>rob\u00f3ticos com <\/strong>t\u00faneis de digitaliza\u00e7\u00e3o que agrupam artigos em caixas e estas, por sua vez, em paletes, sem interven\u00e7\u00e3o do operador. Adequadas para linhas de alta velocidade.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Etiquetadoras de caixas SSCC: Aplicadoras de etiquetas que imprimem e colocam a etiqueta SSCC na caixa de envio ap\u00f3s o agrupamento. Devem estar ligadas ao software de serializa\u00e7\u00e3o para receber e registar o SSCC correto de cada caixa.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Qualifica\u00e7\u00e3o de equipamentos: Os equipamentos de serializa\u00e7\u00e3o farmac\u00eautica utilizados na produ\u00e7\u00e3o comercial, em conformidade com as normas GxP, s\u00e3o normalmente qualificados atrav\u00e9s de atividades de IQ\/OQ e, quando aplic\u00e1vel, de PQ. A documenta\u00e7\u00e3o de qualifica\u00e7\u00e3o serve de base para a valida\u00e7\u00e3o, as inspe\u00e7\u00f5es regulamentares e a gest\u00e3o do ciclo de vida do hardware, do software e da integra\u00e7\u00e3o da linha de produ\u00e7\u00e3o.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n<h2 class=\"wp-block-heading\">Empresas de agrega\u00e7\u00e3o de dados farmac\u00eauticos: como avali\u00e1-las<\/h2>\n\n\n<p class=\"wp-block-paragraph\"><strong>As empresas de agrega\u00e7\u00e3o de dados farmac\u00eauticos<\/strong> fornecem o software e os servi\u00e7os necess\u00e1rios para recolher, gerir e partilhar dados agregados ao longo de toda a cadeia de abastecimento farmac\u00eautica. Ao avaliar <strong>solu\u00e7\u00f5es de agrega\u00e7\u00e3o de dados farmac\u00eauticos<\/strong>, os fabricantes devem avaliar os fornecedores com base em cinco crit\u00e9rios.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Conformidade regulamentar: Que mercados s\u00e3o suportados de forma nativa pela plataforma? A DSCSA e a regulamenta\u00e7\u00e3o da UE relativa \u00e0 febre aftosa s\u00e3o requisitos b\u00e1sicos para muitos fabricantes internacionais; outros mercados podem exigir capacidades adicionais de serializa\u00e7\u00e3o, agrega\u00e7\u00e3o, apresenta\u00e7\u00e3o de relat\u00f3rios ou notifica\u00e7\u00e3o.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>Compatibilidade com o EPCIS: A <\/strong>plataforma <strong>suporta <\/strong>o EPCIS 2.0 tanto para a gera\u00e7\u00e3o de eventos como para o interc\u00e2mbio com parceiros comerciais<strong>? <\/strong>Pode ser necess\u00e1ria a compatibilidade com a vers\u00e3o anterior, o EPCIS 1.2, para garantir a retrocompatibilidade.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Integra\u00e7\u00e3o com sistemas ERP: Uma integra\u00e7\u00e3o consolidada com SAP, Oracle e MES reduz consideravelmente o risco e os prazos de implementa\u00e7\u00e3o. Solicite exemplos de implementa\u00e7\u00f5es com vers\u00f5es de ERP, modelos de dados mestre e requisitos de valida\u00e7\u00e3o semelhantes.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>Escalabilidade: A <\/strong>plataforma <strong>pode <\/strong>ser expandida, passando de uma linha piloto para uma empresa global com v\u00e1rias sedes, sem necessidade de a implementar novamente<strong>? <\/strong>Verifique a capacidade de processamento de n\u00fameros de s\u00e9rie e os limites de armazenamento de eventos.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>Apoio \u00e0 valida\u00e7\u00e3o: O <\/strong>fornecedor <strong>disponibiliza <\/strong>protocolos de IQ\/OQ\/PQ j\u00e1 elaborados, matrizes de rastreabilidade e avalia\u00e7\u00f5es de risco? A documenta\u00e7\u00e3o de valida\u00e7\u00e3o em conformidade com as normas GxP \u00e9 obrigat\u00f3ria e, muitas vezes, o seu \u00e2mbito \u00e9 subestimado.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>Sustentabilidade dos fornecedores: A <\/strong>serializa\u00e7\u00e3o <strong>de produtos farmac\u00eauticos \u00e9 <\/strong>um compromisso a longo prazo. Avalie a estabilidade financeira dos fornecedores, o seu investimento em I&amp;D para se adaptarem \u00e0s altera\u00e7\u00f5es regulamentares e os dados relativos \u00e0 fideliza\u00e7\u00e3o dos clientes.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n<h2 class=\"wp-block-heading\">Software de serializa\u00e7\u00e3o de produtos, acompanhamento e localiza\u00e7\u00e3o, e sele\u00e7\u00e3o de fornecedores<\/h2>\n\n\n<p class=\"wp-block-paragraph\">A serializa\u00e7\u00e3o farmac\u00eautica n\u00e3o funciona de forma isolada. Constitui a base do sistema <strong>de rastreabilidade e localiza\u00e7\u00e3o da serializa\u00e7\u00e3o farmac\u00eautica<\/strong>, e o software de serializa\u00e7\u00e3o que a gere deve ser concebido tendo em conta todo o ciclo de vida da rastreabilidade da cadeia de abastecimento.<\/p>\n\n\n<h3 class=\"wp-block-heading\"><strong>Software de serializa\u00e7\u00e3o de produtos: a camada ao n\u00edvel do artigo<\/strong><\/h3>\n\n\n<p class=\"wp-block-paragraph\"><strong>O software de serializa\u00e7\u00e3o de produtos<\/strong> \u2014 o motor que impulsiona <strong>a serializa\u00e7\u00e3o para o acompanhamento e a rastreabilidade dos produtos<\/strong> \u2014 \u00e9 a aplica\u00e7\u00e3o respons\u00e1vel por atribuir, gerir e acompanhar os n\u00fameros de s\u00e9rie \u00fanicos de cada embalagem de medicamento. Gera intervalos de n\u00fameros de s\u00e9rie, envia trabalhos de impress\u00e3o para as impressoras de c\u00f3digos de barras, captura os resultados da verifica\u00e7\u00e3o do sistema de vis\u00e3o, gere as reimpress\u00f5es e as rejei\u00e7\u00f5es e regista os eventos de agrega\u00e7\u00e3o. \u00c9 o n\u00facleo de gest\u00e3o de dados de todo o programa de serializa\u00e7\u00e3o e o pr\u00e9-requisito para qualquer implementa\u00e7\u00e3o <strong>de acompanhamento e localiza\u00e7\u00e3o no \u00e2mbito da serializa\u00e7\u00e3o farmac\u00eautica<\/strong>.<\/p>\n\n\n<p class=\"wp-block-paragraph\"><strong>O software de rastreio e localiza\u00e7\u00e3o farmac\u00eautica<\/strong> alarga o \u00e2mbito do software de serializa\u00e7\u00e3o de produtos, incorporando a cadeia de abastecimento: gest\u00e3o de eventos EPCIS, troca de dados com parceiros comerciais, conectividade com reposit\u00f3rios normativos e elabora\u00e7\u00e3o de relat\u00f3rios de conformidade. Em conjunto, o software de serializa\u00e7\u00e3o de produtos e <strong>o software de rastreabilidade farmac\u00eautica<\/strong> constituem a plataforma completa <strong>de rastreio e localiza\u00e7\u00e3o farmac\u00eautica<\/strong>.<\/p>\n\n\n<h3 class=\"wp-block-heading\">Acompanhamento e rastreabilidade no setor farmac\u00eautico: a serializa\u00e7\u00e3o como pilar fundamental<\/h3>\n\n\n<p class=\"wp-block-paragraph\">O acompanhamento e a rastreabilidade dos produtos farmac\u00eauticos come\u00e7am com a serializa\u00e7\u00e3o. Sem um n\u00famero de s\u00e9rie \u00fanico em cada unidade, n\u00e3o h\u00e1 identidade que se possa rastrear. A serializa\u00e7\u00e3o para o acompanhamento e a rastreabilidade consiste na implementa\u00e7\u00e3o combinada: a serializa\u00e7\u00e3o cria a identidade; o acompanhamento e a rastreabilidade registam os eventos, movimentos, verifica\u00e7\u00f5es e exce\u00e7\u00f5es associados a essa identidade. A DSCSA, a FMD da UE e outras regulamenta\u00e7\u00f5es nacionais partilham o objetivo de proteger a cadeia de abastecimento leg\u00edtima, mas os seus requisitos em mat\u00e9ria de agrega\u00e7\u00e3o, interc\u00e2mbio de dados EPCIS, apresenta\u00e7\u00e3o de relat\u00f3rios ao reposit\u00f3rio e verifica\u00e7\u00e3o diferem consoante o mercado.<\/p>\n\n\n<h3 class=\"wp-block-heading\"><strong>Sistema de acompanhamento e localiza\u00e7\u00e3o de embalagens farmac\u00eauticas: a serializa\u00e7\u00e3o como dado de entrada<\/strong><\/h3>\n\n\n<p class=\"wp-block-paragraph\">Um sistema de rastreio e localiza\u00e7\u00e3o de embalagens farmac\u00eauticas depende da qualidade dos dados de serializa\u00e7\u00e3o gerados na linha de embalagem. Uma plataforma de serializa\u00e7\u00e3o robusta \u2014que gere n\u00fameros de s\u00e9rie em conformidade com a regulamenta\u00e7\u00e3o, verifique cada c\u00f3digo \u00e0 velocidade da linha de produ\u00e7\u00e3o e registe com precis\u00e3o as rela\u00e7\u00f5es de agrega\u00e7\u00e3o\u2014 \u00e9 o elemento-chave que torna um sistema de rastreabilidade e localiza\u00e7\u00e3o para embalagens farmac\u00eauticas fi\u00e1vel do ponto de vista operacional e em conformidade com a regulamenta\u00e7\u00e3o.<\/p>\n\n\n<h3 class=\"wp-block-heading\"><strong>Solu\u00e7\u00f5es de serializa\u00e7\u00e3o e rastreabilidade<\/strong><\/h3>\n\n\n<p class=\"wp-block-paragraph\">As solu\u00e7\u00f5es de serializa\u00e7\u00e3o e rastreabilidade abrangem tanto a identifica\u00e7\u00e3o ao n\u00edvel do artigo como a gest\u00e3o de eventos da cadeia de abastecimento numa \u00fanica arquitetura validada. Abrangem a gest\u00e3o de n\u00fameros de s\u00e9rie, o hardware de impress\u00e3o e verifica\u00e7\u00e3o, a agrega\u00e7\u00e3o, o armazenamento e a troca de eventos compat\u00edveis com o EPCIS, a conectividade regulamentar e a troca de dados com parceiros comerciais. A diferen\u00e7a em rela\u00e7\u00e3o a uma solu\u00e7\u00e3o de serializa\u00e7\u00e3o independente reside no seu \u00e2mbito de aplica\u00e7\u00e3o: a serializa\u00e7\u00e3o abrange as fases de fabrico e embalagem; as solu\u00e7\u00f5es de serializa\u00e7\u00e3o e rastreabilidade alargam o ciclo de vida dos dados ao longo de toda a cadeia de abastecimento.<\/p>\n\n\n<h3 class=\"wp-block-heading\"><strong>Serializa\u00e7\u00e3o da UE em mat\u00e9ria de febre aftosa: requisitos que o sistema de serializa\u00e7\u00e3o deve cumprir<\/strong><\/h3>\n\n\n<p class=\"wp-block-paragraph\">A serializa\u00e7\u00e3o da FMD da UE (Regulamento Delegado 2016\/161) exige que a maioria das embalagens de medicamentos sujeitos a receita m\u00e9dica comercializados na UE inclua um identificador \u00fanico codificado num c\u00f3digo DataMatrix da GS1, juntamente com um dispositivo antimanipula\u00e7\u00e3o na embalagem. A serializa\u00e7\u00e3o FMD da UE n\u00e3o exige, em geral, a agrega\u00e7\u00e3o, mas os fabricantes que vendem em v\u00e1rios mercados costumam utilizar uma \u00fanica plataforma de serializa\u00e7\u00e3o para gerir simultaneamente os requisitos da FMD da UE, da DSCSA e outros requisitos espec\u00edficos de cada pa\u00eds.<\/p>\n\n\n<h3 class=\"wp-block-heading\"><strong>Empresas de software de serializa\u00e7\u00e3o: crit\u00e9rios de avalia\u00e7\u00e3o<\/strong><\/h3>\n\n\n<p class=\"wp-block-paragraph\">Ao escolher entre as empresas de software de serializa\u00e7\u00e3o, os fabricantes devem avaliar: o \u00e2mbito regulamentar, o grau de integra\u00e7\u00e3o com os sistemas ERP e MES, a integra\u00e7\u00e3o entre hardware e software, a arquitetura de escalabilidade, a gest\u00e3o de eventos EPCIS e a compatibilidade com a valida\u00e7\u00e3o GxP. As empresas de software de serializa\u00e7\u00e3o que combinam equipamentos de linha, software e conectividade regulamentar podem reduzir o risco do projeto, especialmente em casos de moderniza\u00e7\u00e3o, renova\u00e7\u00e3o e implementa\u00e7\u00f5es em v\u00e1rios locais.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n<h2 class=\"wp-block-heading\">Solu\u00e7\u00f5es de serializa\u00e7\u00e3o farmac\u00eautica: a plataforma AVG<\/h2>\n\n\n<p class=\"wp-block-paragraph\">O Antares Vision Group oferece solu\u00e7\u00f5es integrais de serializa\u00e7\u00e3o farmac\u00eautica \u2014 desde equipamentos de serializa\u00e7\u00e3o farmac\u00eautica na linha de embalagem at\u00e9 software de serializa\u00e7\u00e3o empresarial e conectividade regulamentar \u2014 concebidas para fabricantes, CMO, CDMO e titulares de autoriza\u00e7\u00f5es de introdu\u00e7\u00e3o no mercado (MAH) com requisitos complexos em v\u00e1rios mercados.<\/p>\n\n\n<p class=\"wp-block-paragraph\">A plataforma AVG permite a serializa\u00e7\u00e3o e a rastreabilidade de produtos farmac\u00eauticos em toda a arquitetura: gera\u00e7\u00e3o de n\u00fameros de s\u00e9rie, integra\u00e7\u00e3o de \u00abimpress\u00e3o e verifica\u00e7\u00e3o\u00bb com impressoras de linha e sistemas de vis\u00e3o, agrega\u00e7\u00e3o de produtos farmac\u00eauticos ao n\u00edvel da caixa e do palete, gest\u00e3o de eventos compat\u00edvel com EPCIS, integra\u00e7\u00e3o com ERP\/MES e conectividade com os sistemas reguladores ou de parceiros comerciais relevantes. A plataforma \u00e9 compat\u00edvel com diferentes formatos de embalagem \u2014 incluindo configura\u00e7\u00f5es de blister, frasco, caixa de cart\u00e3o e produtos injet\u00e1veis \u2014 com op\u00e7\u00f5es de hardware e software espec\u00edficas para cada linha de embalagem.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n<h2 class=\"wp-block-heading\"><strong>Aspectos destacados da plataforma<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Serializa\u00e7\u00e3o de alta velocidade em v\u00e1rios formatos de embalagem, incluindo produtos em blister, injet\u00e1veis, em caixa e engarrafados, consoante a configura\u00e7\u00e3o da linha<\/li>\n\n\n\n<li>C\u00e9lulas de agrupamento automatizadas ao n\u00edvel da caixa e do palete: configura\u00e7\u00f5es rob\u00f3ticas e manuais<\/li>\n\n\n\n<li>Solu\u00e7\u00f5es de agrega\u00e7\u00e3o de dados farmac\u00eauticos que apoiam as opera\u00e7\u00f5es de armazenamento, venda por grosso e distribui\u00e7\u00e3o<\/li>\n\n\n\n<li>Apoio em mat\u00e9ria de conformidade regulamentar em v\u00e1rios mercados no \u00e2mbito da DSCSA, da regulamenta\u00e7\u00e3o da UE relativa \u00e0 febre aftosa e de outros requisitos nacionais de serializa\u00e7\u00e3o ou rastreabilidade<\/li>\n\n\n\n<li>Op\u00e7\u00f5es de integra\u00e7\u00e3o entre ERP e MES para SAP, Oracle e outros sistemas empresariais<\/li>\n\n\n\n<li>Modelos de implementa\u00e7\u00e3o na nuvem, nas pr\u00f3prias instala\u00e7\u00f5es e h\u00edbridos para software de serializa\u00e7\u00e3o<\/li>\n\n\n\n<li>Pacotes de documenta\u00e7\u00e3o de IQ\/OQ\/PQ para apoiar a valida\u00e7\u00e3o GxP de hardware, software e integra\u00e7\u00e3o de linhas de produ\u00e7\u00e3o<\/li>\n<\/ul>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<div class=\"pure-container kbutton \"\n style=\"\">\n            <a class=\"gtm__conditionButton kbutton__button\" href=\"https:\/\/antaresvisiongroup.com\/lifescience\/track-and-trace\/\" target=\"\"\n                    >\n            <div class=\"kbutton__buttonTitle\">DISCOVER OUR SOLUTIONS<\/div>\n            <svg id=\"Livello_button\" data-name=\"Livello 2\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"14\" height=\"14\" viewBox=\"0 0 14 14\">\n                <defs>\n                    <div class=\"k-block-css\" hidden data-css=\"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\"><\/div>\n                    <clipPath id=\"clip-path-1\">\n                        <polygon class=\"cls-1\" points=\"2.099 12.999 1 11.9 10.344 2.557 1.824 2.557 1.824 1 13 1 13 12.176 11.443 12.176 11.443 3.656 2.099 12.999\"><\/polygon>\n                    <\/clipPath>\n                    <clipPath id=\"clip-path-2-1\">\n                        <rect class=\"cls-1\" x=\"-1141\" y=\"-1543\" width=\"1680\" height=\"4770.9999\"><\/rect>\n                    <\/clipPath>\n                    <clipPath id=\"clip-path-3-1\">\n                        <rect class=\"cls-1\" x=\"1\" y=\"1\" width=\"12\" height=\"12\"><\/rect>\n                    <\/clipPath>\n                <\/defs>\n                <title>k-arrow-blu<\/title>\n                <g class=\"cls-2\"><g class=\"cls-3\"><g class=\"cls-4\"><g class=\"cls-4\"><rect class=\"cls-5\" width=\"14\" height=\"14\"><\/rect>\n                                <rect class=\"cls-5\" width=\"14\" height=\"14\"><\/rect>\n                            <\/g><\/g><\/g><\/g>\n            <\/svg>\n        <\/a>\n    <\/div>\n\n<div class=\"k-block-css\" hidden data-css=\"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\"><\/div>\n\n<div class=\"k-block-js\" hidden data-js=\"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\"><\/div>\n\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n<\/div>\n\n\n\n<!-- F.A.Q. -->\n<div class=\"kfaq\">\n    <div class=\"pure-container-fluid\">\n        <div class=\"pure-container\">\n            <div class=\"pure-g\">\n                <div class=\"pure-u-1-1\">\n                                            <h2 class=\"kfaq__title\">Perguntas frequentes (FAQ)<\/h2>\n                                    <\/div>\n\n                <div class=\"pure-u-1-1 kfaq__colLeft\">\n                    <div class=\"kfaq__colLeftContDesc tabs__container\">\n                        \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck1\">\n                                <label class=\"tab__singleTitle\" for=\"chck1\"><h3>What is pharmaceutical serialization?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Pharmaceutical serialization is the process of assigning a unique identifier \u2014 a serial number \u2014 to each individual drug package. The identifier is typically encoded in a GS1 DataMatrix 2D barcode and printed on the secondary packaging or relevant saleable unit. Pharmaceutical serialization is a foundational compliance requirement for DSCSA in the United States, EU FMD in the European Union, and many equivalent national drug traceability regulations worldwide.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck2\">\n                                <label class=\"tab__singleTitle\" for=\"chck2\"><h3>What is pharmaceutical serialization and traceability?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Pharmaceutical serialization and traceability is the combined capability of assigning unique identifiers to every drug unit (serialization) and tracking the movement history of those units across the supply chain (traceability). Serialization creates the identity; traceability records what happens to that identity at supply chain events. The scope of serialization, aggregation, EPCIS exchange, and repository reporting varies by regulation and market.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck3\">\n                                <label class=\"tab__singleTitle\" for=\"chck3\"><h3>What does serialization software do in pharmaceutical manufacturing?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Serialization software in pharmaceutical manufacturing manages the full lifecycle of drug unit identifiers \u2014 from serial number generation and assignment to print job management, code quality verification, aggregation event recording, commissioning, rework, and supply chain event reporting. It sits between the packaging line hardware and enterprise systems such as ERP and MES, connecting outward to regulatory repositories, EPCIS networks, or trading partner exchange platforms where required.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck4\">\n                                <label class=\"tab__singleTitle\" for=\"chck4\"><h3>What are serialization solutions for pharmaceutical manufacturers?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Serialization solutions for pharmaceutical manufacturers are validated combinations of line hardware and software that enable compliance with drug serialization regulations. A complete serialization solution can cover serial number generation, print-and-verify at the packaging line, aggregation of items into cases and pallets, EPCIS event management, regulatory connectivity, ERP\/MES integration, and GxP validation support. Serialization solutions range from single-line deployments to global multi-site enterprise platforms.<\/p>\n<p>&nbsp;<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck5\">\n                                <label class=\"tab__singleTitle\" for=\"chck5\"><h3>What is a pharmaceutical serialization solution?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>A pharmaceutical serialization solution is a validated implementation of serialization hardware and software configured for a manufacturer&#8217;s specific packaging formats, product portfolio, and target markets. It includes line integration \u2014 printer, camera, reject system, and aggregation devices \u2014 serialization software, regulatory connectivity, and documentation to support IQ\/OQ\/PQ validation activities.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck6\">\n                                <label class=\"tab__singleTitle\" for=\"chck6\"><h3>What is pharmaceutical data aggregation?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Pharmaceutical data aggregation is the process of recording and managing the parent-child relationships between serialized drug units at different packaging levels \u2014 item, case, and pallet. It enables distributors, warehouses, and other trading partners to verify a case or pallet by scanning a single barcode, reducing operational complexity. Pharmaceutical data aggregation events are typically managed in an EPCIS-compatible event layer and exchanged with trading partners where required.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck7\">\n                                <label class=\"tab__singleTitle\" for=\"chck7\"><h3>What is pharmaceutical aggregation in serialization?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Pharmaceutical aggregation in serialization is the process of linking serialized drug units to the cases and pallets that contain them. When a case is aggregated, item serial numbers inside it are linked to the case identifier. When a pallet is aggregated, case identifiers are linked to the pallet identifier \u2014 enabling supply chain visibility through the digital parent-child hierarchy.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck8\">\n                                <label class=\"tab__singleTitle\" for=\"chck8\"><h3>What is serialization and aggregation in pharmaceutical packaging?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Serialization and aggregation in pharmaceutical packaging are two complementary processes. Serialization assigns a unique identifier to each individual drug pack at item level. Aggregation records the parent-child relationships between serialized items and the cases and pallets that contain them. Together, they support pharmaceutical traceability and are required or operationally expected under several major drug traceability frameworks, with requirements varying by market.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck9\">\n                                <label class=\"tab__singleTitle\" for=\"chck9\"><h3>What is pharma serialization equipment?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Pharma serialization equipment is the physical hardware used to print, verify, and manage unique serial numbers on pharmaceutical packaging at production speed. It includes coding systems (inkjet, laser, TTO) for DataMatrix printing, camera-based vision systems for code verification, reject mechanisms for defective codes, aggregation workstations for case and pallet linking, and SSCC case labelers. Pharma serialization equipment used in GxP environments is qualified and validated as part of the packaging line.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck10\">\n                                <label class=\"tab__singleTitle\" for=\"chck10\"><h3>What is blister serialization in pharmaceutical manufacturing?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Blister serialization is the application of pharmaceutical serialization to blister-packed solid-dose drug products. The serialized code is typically applied to the folding carton or saleable unit associated with the blister pack and verified at the blister line or cartoner. Blister serialization requires coding hardware, camera systems for code quality verification, rejection management, and software integration with the plant-level serialization system.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck11\">\n                                <label class=\"tab__singleTitle\" for=\"chck11\"><h3>Who are pharmaceutical data aggregation companies?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Pharmaceutical data aggregation companies are technology vendors that provide the software and services needed to capture, manage, and exchange aggregation data across the pharmaceutical supply chain. They include serialization platform vendors with integrated aggregation modules, contract serialization service providers, interoperability network operators, and system integrators. Key evaluation criteria include regulatory coverage, EPCIS compatibility, ERP integration, scalability, and validation support documentation.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck12\">\n                                <label class=\"tab__singleTitle\" for=\"chck12\"><h3>What is product serialization software?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Product serialization software is the application that generates, manages, and tracks unique serial numbers for individual drug packages throughout the manufacturing and packaging process. It handles serial number range management, print job generation, code quality verification results, aggregation data capture, EPCIS event creation, rework, decommissioning, and ERP\/MES integration. It is the central data management layer of a pharmaceutical serialization program and the prerequisite for pharmaceutical serialization track and trace.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck13\">\n                                <label class=\"tab__singleTitle\" for=\"chck13\"><h3>Who are serialization software companies for pharmaceuticals?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Serialization software companies are technology vendors providing the software platforms used to manage pharmaceutical serialization programs. Key evaluation criteria include regulatory country coverage, EPCIS event management, ERP\/MES integration maturity, hardware-software integration, scalability from single line to global enterprise, and GxP validation documentation support.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck14\">\n                                <label class=\"tab__singleTitle\" for=\"chck14\"><h3>What is EU FMD serialization?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>EU FMD serialization is mandated by the EU Falsified Medicines Directive and Delegated Regulation 2016\/161. It requires most prescription medicinal product packs sold in the EU to carry a unique identifier \u2014 product code, serial number, batch number, and expiry date \u2014 encoded in a GS1 DataMatrix barcode, together with an anti-tampering device. EU FMD serialization does not generally require aggregation, but manufacturers selling in multiple markets may implement aggregation to meet DSCSA or other country-specific requirements on the same platform.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck15\">\n                                <label class=\"tab__singleTitle\" for=\"chck15\"><h3>What is pharmaceutical traceability software?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Pharmaceutical traceability software manages end-to-end traceability of drug products across the supply chain. It extends product serialization software by adding supply chain event management \u2014 EPCIS event recording, trading partner data exchange, verification workflows, and regulatory reporting where required. Together with product serialization software, it constitutes the broader pharma track and trace platform needed for multi-market compliance.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck16\">\n                                <label class=\"tab__singleTitle\" for=\"chck16\"><h3>What are serialization and traceability solutions?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Serialization and traceability solutions are integrated technology implementations addressing both item-level drug identification (serialization) and supply chain event management (traceability) in a single validated architecture. They cover serial number management, print-and-verify hardware, case and pallet aggregation, EPCIS-compatible event storage, regulatory connectivity, and trading partner data exchange.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                            \n                            <div class=\"tab__single\">\n                                <input type=\"checkbox\" id=\"chck17\">\n                                <label class=\"tab__singleTitle\" for=\"chck17\"><h3>What is pharmaceutical serialization track and trace?<\/h3><\/label>\n                                <div class=\"tab__singleContent\">\n                                    <div class=\"tab__singleContentInt\">\n                                        <p>Pharmaceutical serialization track and trace is the combined implementation of item-level serialization and supply chain event management. The serialization component assigns a globally unique identifier to every drug pack at the packaging line. The track and trace component records subsequent supply chain events in an EPCIS-compatible event layer or trading partner exchange model, creating an auditable chain of custody from manufacturing to dispensing or distribution, depending on market requirements.<\/p>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                                                <\/div>\n                <\/div>\n\n            <\/div>\n        <\/div>\n    <\/div>\n\n<\/div>\n\n<div class=\"k-block-css\" hidden data-css=\"CiAgICAucGFnZS10ZW1wbGF0ZS1wYWdlX3Byb2R1Y3QgLmtmYXF7bWFyZ2luLWJvdHRvbTogMDt9CiAgICAua2ZhcXtiYWNrZ3JvdW5kLWNvbG9yOiAjZmJmYmZiOyBib3JkZXItcmFkaXVzOiAwOyBwYWRkaW5nLXRvcDogODBweDsgcGFkZGluZy1ib3R0b206IDgwcHg7IG1hcmdpbi1ib3R0b206IDEwMHB4O30KICAgIC5rZmFxIGltZ3tib3JkZXItcmFkaXVzOiAzMHB4OyB3aWR0aDogMTAwJTsgaGVpZ2h0OiBhdXRvO30KICAgIC5rZmFxX19jb2xMZWZ0e2Rpc3BsYXk6IGZsZXg7IGFsaWduLWl0ZW1zOiBjZW50ZXI7fQogICAgLmtmYXFfX2NvbExlZnRDb250IGgye2ZvbnQtc2l6ZTogNDBweDsgcG9zaXRpb246IHJlbGF0aXZlOyBwYWRkaW5nLWxlZnQ6IDMwcHg7IHBhZGRpbmctdG9wOiAyMHB4OyBwYWRkaW5nLWJvdHRvbTogMjBweDt9CiAgICAua2ZhcV9fY29sTGVmdENvbnREZXNje3dpZHRoOiAxMDAlO30KICAgIC5rZmFxX19jb2xMZWZ0IGF7Y29sb3I6ICMyMjIyMjI7IGZvbnQtd2VpZ2h0OiBib2xkOyBtYXJnaW4tbGVmdDogMzBweDt9CgogICAgLyogbmV3ICovCiAgICAua2ZhcV9fY29udFRpdGxle2Rpc3BsYXk6IGZsZXg7IGFsaWduLWl0ZW1zOiBjZW50ZXI7IG1hcmdpbi1ib3R0b206IDE1cHg7fQogICAgLmtmYXFfX2NvbnRUaXRsZSBpbWd7d2lkdGg6IDIxcHg7IGhlaWdodDogYXV0bzsgbWFyZ2luLXJpZ2h0OiAxMHB4O30KICAgIC5rZmFxX19jb250VGl0bGUgaDJ7bWFyZ2luLWJvdHRvbTogMDsgZm9udC1zaXplOiAyMHB4OyBmb250LXdlaWdodDogNjAwOyB3aWR0aDogY2FsYygxMDAlIC0gMzFweCk7fQogICAgLmtmYXFfX3RpdGxle2ZvbnQtc2l6ZTogMzJweDsgZm9udC1mYW1pbHk6ICdFeG8nLCBzYW5zLXNlcmlmOyBtYXJnaW4tYm90dG9tOiAzMHB4OyBsaW5lLWhlaWdodDogMS4yOwogICAgICAgIGNvbG9yOiByZ2IoLCwpO30KCiAgICAvKiBhY2NvcmRpb24gLyBkcm9wZG93biAqLwogICAgLmtmYXEgLnRhYnNfX2NvbnRhaW5lciBpbnB1dFt0eXBlPSJjaGVja2JveCJdLCAudGFic19fY29udGFpbmVyIGlucHV0W3R5cGU9InJhZGlvIl17cG9zaXRpb246IGFic29sdXRlOyBvcGFjaXR5OiAwOyB6LWluZGV4OiAtMTt9CiAgICAua2ZhcSAudGFic19fY29udGFpbmVyIHtvdmVyZmxvdzogaGlkZGVuOyB9CiAgICAua2ZhcSAudGFiX19zaW5nbGU6Zmlyc3QtY2hpbGR7Ym9yZGVyLXRvcDogMXB4IHNvbGlkICMwODA3MEExQTt9CiAgICAua2ZhcSAudGFiX19zaW5nbGV7d2lkdGg6IDEwMCU7IG92ZXJmbG93OiBoaWRkZW47IGJhY2tncm91bmQtY29sb3I6IHRyYW5zcGFyZW50OyBtYXJnaW4tYm90dG9tOiAwcHg7IHBhZGRpbmc6IDE4cHggMTVweCAwIDE1cHg7CiAgICAgICAgYm9yZGVyLWJvdHRvbTogMXB4IHNvbGlkICMwODA3MEExQTt9CiAgICAua2ZhcSAudGFiX19zaW5nbGVUaXRsZXtoZWlnaHQ6IGZpdC1jb250ZW50OyBoZWlnaHQ6IC1tb3otZml0LWNvbnRlbnQ7IGRpc3BsYXk6IGZsZXg7IGp1c3RpZnktY29udGVudDogc3BhY2UtYmV0d2VlbjsgY3Vyc29yOiBwb2ludGVyOwogICAgICAgIHBvc2l0aW9uOiByZWxhdGl2ZTsgYWxpZ24taXRlbXM6IGNlbnRlcjsgZm9udC13ZWlnaHQ6IDMwMDsgY29sb3I6ICMwQjEwMjI7IGZvbnQtZmFtaWx5OiAiSG9zdCBHcm90ZXNrIiwgc2Fucy1zZXJpZjsgZm9udC1zaXplOiAxOHB4O30KICAgIC5rZmFxIC50YWJfX3NpbmdsZVRpdGxlOjphZnRlciB7Y29udGVudDogdXJsKCJodHRwczovL2FudGFyZXN2aXNpb25ncm91cC5jb20vbGlmZXNjaWVuY2Uvd3AtY29udGVudC90aGVtZXMvbWVyY3VyeV90aGVtZS9hc3NldHMvaW1hZ2VzL2tfZmFxX3BsdXMuc3ZnIik7IHRleHQtYWxpZ246IGNlbnRlcjsgcG9zaXRpb246IGFic29sdXRlOwogICAgICAgIHJpZ2h0OiAzMHB4OyB3aWR0aDogMjBweDsgaGVpZ2h0OiAyMHB4OyB0b3A6IDBweDt9CiAgICAua2ZhcSAudGFiX19zaW5nbGVDb250ZW50IHttYXgtaGVpZ2h0OiAxcHg7IHRyYW5zaXRpb246IGFsbCAwLjRzOyBoZWlnaHQ6IDFweH0KICAgIC5rZmFxIC50YWJfX3NpbmdsZUNvbnRlbnRJbnR7YmFja2dyb3VuZC1jb2xvcjogdHJhbnNwYXJlbnQ7IGZvbnQtd2VpZ2h0OiA0MDA7IGJvcmRlci10b3A6IDA7ICAgICB3aWR0aDogY2FsYygxMDAlIC0gMzBweCk7fQoKICAgIC5rZmFxIC50YWJzX19jb250YWluZXIgaW5wdXQ6Y2hlY2tlZCArIC50YWJfX3NpbmdsZVRpdGxlIHt9CiAgICAua2ZhcSAudGFic19fY29udGFpbmVyIGlucHV0OmNoZWNrZWQgKyAudGFiX19zaW5nbGVUaXRsZTo6YWZ0ZXIge2NvbnRlbnQ6IHVybCgiaHR0cHM6Ly9hbnRhcmVzdmlzaW9uZ3JvdXAuY29tL2xpZmVzY2llbmNlL3dwLWNvbnRlbnQvdGhlbWVzL21lcmN1cnlfdGhlbWUvYXNzZXRzL2ltYWdlcy9rX2ZhcV9taW51cy5zdmciKTsKICAgICAgICB3aWR0aDogMjBweDsgaGVpZ2h0OiAyMHB4OyB0b3A6IDBweDt9CiAgICAua2ZhcSAudGFic19fY29udGFpbmVyIGlucHV0OmNoZWNrZWQgfiAudGFiX19zaW5nbGVDb250ZW50IHttYXgtaGVpZ2h0OiAxMDB2aDsgdHJhbnNpdGlvbjogYWxsIDFzOyBoZWlnaHQ6IDEwMCU7fQogICAgLmtmYXEgLnRhYl9fc2luZ2xlQ29udGVudEludHtwYWRkaW5nLWJvdHRvbTogNDBweDsgbWF4LXdpZHRoOiA3MCU7IHBhZGRpbmctbGVmdDogNDBweDt9CgogICAgLmtmYXEgLnRhYl9fc2luZ2xlVGl0bGUgbGl7bGlzdC1zdHlsZTogbm9uZTt9CiAgICAua2ZhcSAudGFiX19zaW5nbGVUaXRsZSBoM3tmb250LWZhbWlseTogIk9wZW4gU2FucyIsIHNhbnMtc2VyaWY7IGZvbnQtd2VpZ2h0OiA0MDA7IGZvbnQtc2l6ZTogMThweDsgbWFyZ2luLWJvdHRvbTogMDt9CgogICAgLyogbW9iaWxlICovCiAgICBAbWVkaWEgc2NyZWVuIGFuZCAobWF4LXdpZHRoOiA3NjdweCkgewogICAgICAgIC5rZmFxIC50YWJfX3NpbmdsZVRpdGxle3BhZGRpbmctcmlnaHQ6IDQwcHg7fQogICAgICAgIC5rZmFxe21hcmdpbi10b3A6IDBweDt9CiAgICAgICAgLmtmYXEgLmtmYXFfX2NvbEltZ3twYWRkaW5nLWxlZnQ6IDAhaW1wb3J0YW50OyBwYWRkaW5nLXJpZ2h0OiAwIWltcG9ydGFudDt9CiAgICAgICAgLmtmYXEgaW1ne2JvcmRlci1yYWRpdXM6IDA7fQogICAgICAgIC5rZmFxX19jb2xMZWZ0Q29udCBoMntmb250LXNpemU6IDM1cHg7IG1hcmdpbi10b3A6IDMwcHg7fQogICAgICAgIC5rZmFxX19jb2xMZWZ0Q29udCB7d2lkdGg6IDEwMCU7bWFyZ2luLWxlZnQ6IDBweDt9CiAgICAgICAgLmtmYXFfX2NvbExlZnRDb250RGVzY3ttYXJnaW4tbGVmdDogMDsgbWFyZ2luLXRvcDogMzBweDsgb3ZlcmZsb3cteDogaGlkZGVuOwogICAgICAgICAgICBvdmVyZmxvdy15OiBoaWRkZW47fQoKICAgICAgICAua2ZhcXtib3JkZXItcmFkaXVzOiAwOyBwYWRkaW5nLXRvcDogNDBweDsgcGFkZGluZy1ib3R0b206IDIwcHg7IG1hcmdpbi1ib3R0b206IDYwcHg7fQogICAgICAgIC5rZmFxX190aXRsZXtmb250LXNpemU6IDQwcHg7IG1hcmdpbi1ib3R0b206IDBweDt9CiAgICAgICAgLmtmYXEgLnRhYl9fc2luZ2xlQ29udGVudEludHttYXgtd2lkdGg6IHVuc2V0OyBwYWRkaW5nLWxlZnQ6IDA7fQoKICAgICAgICAua2ZhcSAudGFiX19zaW5nbGVUaXRsZXtmb250LXNpemU6IDE2cHg7IHBhZGRpbmctcmlnaHQ6IDc3cHg7fQogICAgICAgIC50YWJfX3NpbmdsZUNvbnRlbnRJbnR7Zm9udC1zaXplOiAxNnB4O30KCiAgICAgICAgLmtmYXEgLnRhYnNfX2NvbnRhaW5lciBpbnB1dDpjaGVja2VkIH4gLnRhYl9fc2luZ2xlQ29udGVudHttYXgtaGVpZ2h0OiAzMDB2aDt9CgogICAgfQoKICAgIC8qIGlwYWQgKi8KICAgIEBtZWRpYSBzY3JlZW4gYW5kIChtaW4td2lkdGg6IDc2OHB4KSBhbmQgIChtYXgtd2lkdGg6IDk5MnB4KXsKICAgICAgICAua2ZhcSAudGFiX19zaW5nbGVUaXRsZXtwYWRkaW5nLXJpZ2h0OiA4MHB4O30KICAgICAgICAua2ZhcXttYXJnaW4tdG9wOiAwcHg7fQogICAgICAgIC5rZmFxX19jb2xMZWZ0Q29udCB7d2lkdGg6IDEwMCU7bWFyZ2luLWxlZnQ6IDBweDt9CiAgICAgICAgLmtmYXEgLnRhYnNfX2NvbnRhaW5lciBpbnB1dDpjaGVja2VkIH4gLnRhYl9fc2luZ2xlQ29udGVudHttYXgtaGVpZ2h0OiAyMDB2aDt9CgogICAgICAgIC5rZmFxX190aXRsZXtmb250LXNpemU6IDQwcHg7fQogICAgICAgIC5rZmFxe21hcmdpbi1ib3R0b206IDEwMHB4OyBib3JkZXItcmFkaXVzOiAwO30KICAgICAgICAua2ZhcSAudGFiX19zaW5nbGVDb250ZW50SW50e3BhZGRpbmctbGVmdDogMDsgbWF4LXdpZHRoOiA5MCU7fQogICAgfQoKICAgIC8qIGlwYWQgcHJvICovCiAgICBAbWVkaWEgc2NyZWVuIGFuZCAobWluLXdpZHRoOiA5OTJweCkgYW5kICAobWF4LXdpZHRoOiAxMjAwcHgpewogICAgICAgIC5rZmFxIC50YWJfX3NpbmdsZVRpdGxle3BhZGRpbmctcmlnaHQ6IDgwcHg7fQogICAgfQoKICAgIC8qID4gMmsgKi8KICAgIEBtZWRpYSBzY3JlZW4gYW5kIChtaW4td2lkdGg6IDIwMDBweCl7CiAgICAgICAgLmtmYXF7bWF4LXdpZHRoOiB1bnNldDsgbWFyZ2luLWxlZnQ6IGF1dG87bWFyZ2luLXJpZ2h0OiBhdXRvO30KICAgIH0KCg==\"><\/div>\n\n<div class=\"k-block-js\" hidden data-js=\"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\"><\/div>\n\n\n    <div class=\"k-block-js\" hidden data-js=\"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\"><\/div>\n\n\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Serializa\u00e7\u00e3o e agrega\u00e7\u00e3o de produtos farmac\u00eauticos Desde a identifica\u00e7\u00e3o \u00fanica ao n\u00edvel do artigo at\u00e9&#8230;<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-9780","page","type-page","status-publish","hentry"],"acf":[],"lang":"pt","translations":{"pt":9780,"es":9776,"en":9579},"pll_sync_post":{},"_links":{"self":[{"href":"https:\/\/antaresvisiongroup.com\/lifescience\/wp-json\/wp\/v2\/pages\/9780","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/antaresvisiongroup.com\/lifescience\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/antaresvisiongroup.com\/lifescience\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/antaresvisiongroup.com\/lifescience\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/antaresvisiongroup.com\/lifescience\/wp-json\/wp\/v2\/comments?post=9780"}],"version-history":[{"count":2,"href":"https:\/\/antaresvisiongroup.com\/lifescience\/wp-json\/wp\/v2\/pages\/9780\/revisions"}],"predecessor-version":[{"id":9782,"href":"https:\/\/antaresvisiongroup.com\/lifescience\/wp-json\/wp\/v2\/pages\/9780\/revisions\/9782"}],"wp:attachment":[{"href":"https:\/\/antaresvisiongroup.com\/lifescience\/wp-json\/wp\/v2\/media?parent=9780"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}